fda warning letter glp-1 october 2025 U.S. | The American people deserve an FDA that is responsive and efficient. Five drugs have been approved so far under the national priority FDA issued 30 warning letters
Description
Weight Loss Q&A Am I a good candidate for GLP-1 treatment

Pros Cons : What your doctor might consider Side effects Across all GLP-1s, around one in four people experience nausea, bloating, diarrhea, or constipation

Some have added BNPL options, but availability changes frequently as these partnerships evolve
[DOI] [PubMed] [Google Scholar] 140.Coester B, et al

Significantly, emulating this reduction in Akt/PKB signalling in the prefrontal cortex of mice resulted in cognitive impairments similar to those observed in human patients